
IBO Valuation
Impact Biomedical Inc
- Overview
- Forecast
- Valuation
- Earnings
IBO Relative Valuation
IBO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IBO is overvalued; if below, it's undervalued.
Historical Valuation
Impact Biomedical Inc (IBO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Impact Biomedical Inc (IBO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:0.70
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.24
P/B
Median3y
1.42
Median5y
1.42
-49.35
FCF Yield
Median3y
-32.80
Median5y
-32.80
Competitors Valuation Multiple
The average P/S ratio for IBO's competitors is 0.20, providing a benchmark for relative valuation. Impact Biomedical Inc Corp (IBO) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

MIGI
Mawson Infrastructure Group Inc
0.540
USD
0.00%

ASPS
Altisource Portfolio Solutions SA
11.500
USD
-4.17%

NCL
Northann Corp
0.193
USD
+2.11%

JFU
9F Inc
1.610
USD
-6.40%

GIGM
GigaMedia Ltd
1.460
USD
0.00%

SOHO
Sotherly Hotels Inc
0.878
USD
+0.80%

SLNH
Soluna Holdings Inc
0.537
USD
-6.44%

MCVT
Mill City Ventures III Ltd
5.900
USD
+218.92%

LFWD
Lifeward Ltd
0.775
USD
-6.29%

AFMD
Affimed NV
0
USD
-53.99%
FAQ

Is Impact Biomedical Inc (IBO) currently overvalued or undervalued?
Impact Biomedical Inc (IBO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Impact Biomedical Inc (IBO) is between to according to relative valuation methord.

What is Impact Biomedical Inc (IBO) fair value?

How does IBO's valuation metrics compare to the industry average?

What is the current P/B ratio for Impact Biomedical Inc (IBO) as of Jul 27 2025?

What is the current FCF Yield for Impact Biomedical Inc (IBO) as of Jul 27 2025?

What is the current Forward P/E ratio for Impact Biomedical Inc (IBO) as of Jul 27 2025?
